Carl Zeiss Meditec AG header image

Carl Zeiss Meditec AG

AFX

Equity

ISIN DE0005313704 / Valor 1055489

Xetra (2026-07-03)
EUR 28.74+3.83%

Carl Zeiss Meditec AG
UMushroom community rating:

star star star star star
4.40 5 votes No rating yet
NegativeNeutralPositive

About company

Carl Zeiss Meditec AG, headquartered in Jena, Germany and listed on the Frankfurt Stock Exchange, is a medical-technology company focused principally on devices, software and consumables for eye care and microsurgery. Its product portfolio spans diagnostic imaging systems (including optical coherence tomography and retinal imaging), surgical platforms and visualization equipment (such as surgical microscopes and laser systems for refractive and cataract procedures), as well as intraocular lenses, disposables and clinical IT solutions that support workflow and data management. The company sells capital equipment to hospitals, eye clinics and private practices worldwide and generates recurring revenue from consumables, service contracts and software, while investing in research and regulatory approvals to maintain and extend its market position in ophthalmology and related microsurgical fields.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-46.6%1Y
-71.1%3Y
-82.5%5Y

Performance

43.5%1Y
43.7%3Y
41.0%5Y

Volatility

Market cap

2878 M

Market cap (USD)

Daily traded volume (Shares)

288,600

Daily traded volume (Shares)

1 day high/low

47.3 / 46.28

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.40

5 votes
Performance:
starstarstarstarstar
4.20
Innovation:
starstarstarstarstar
4.80
Society:
starstarstarstarstar
4.40
Nature:
starstarstarstarstar
4.20
Luba Schoenig
Switzerland, 08 Jun 2023
star star star star star
Highly innovative company who is expected to be one of the key riders on the virtual reality glasses wave
Tonia Zimmermann
Switzerland, 06 Jun 2023
star star star star star
Big potential ahead of them given the use of their solutions in apple products
Laura Bischofberger
Switzerland, 06 Jun 2023
star star star star star
Interessante Performance über die letzten Jahre. & mit der Vorstellung vom neuen Produkt gestern durch Apple, ist ein gross Auftrag garantiert

EQUITIES OF THE SAME SECTOR

Tilray Brands Inc
Tilray Brands Inc Tilray Brands Inc Valor: 42386407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.29%USD 4.62
Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.44%USD 25.39
Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc Ironwood Pharmaceuticals Inc Valor: 10773079
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.10%USD 4.33
Abbott India Limited
Abbott India Limited Abbott India Limited Valor: 561999
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%INR 25,850.45
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.32%USD 8.39
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc Valor: 25337263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.41%USD 114.17
Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals Inc Catalyst Pharmaceuticals Inc Valor: 2649177
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.03%USD 31.45
Astrana Health Inc
Astrana Health Inc Astrana Health Inc Valor: 28041888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.28%USD 49.17
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.29%USD 19.64
Schrodinger Inc
Schrodinger Inc Schrodinger Inc Valor: 51947209
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.99%USD 16.88